bexarotene

bexarotene information and resources from the National Cancer Institute

NCI Thesaurus | bexarotene

A synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties. Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression. NCI Thesaurus | bexarotene

A synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties. Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression.

Bexarotene Gel 1% Enhances Efficacy of Phototherapy for Psoriasis ... Mar 6, 2006
DG News SAN FRANCISCO, CA -- March 6, 2006 -- Treatment with bexarotene gel 1% appears to enhance the efficacy of narrowband ultraviolet B (UVB) phototherapy with ...

bexarotene -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org